Dove Medical Press acquires Journal of Parkinsonism and Restless Legs Syndrome - KTRE.com | Lufkin and Nacogdoches, Texas

Dove Medical Press acquires Journal of Parkinsonism and Restless Legs Syndrome

Posted:

This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.

SOURCE: Dove Medical Press

Open Access, Peer-Reviewed Neuroscience Journal publishes original research, case reports and clinical teaching cases.

Auckland, New Zealand (PRWEB) August 21, 2012

Journal of Parkinsonism and Restless Legs Syndrome (JPRLS) is written exclusively for the medical and scientific community wishing to read related research, policy, phenomenology, literature, history, and treatment. The journal was created to provide a forum for international debate on the various aspects of Parkinsonism and Restless Legs Syndrome.

According to Founding Editor-in-Chief, Dr. Abdul Qayyum Rana, the journal reports on updates of various types of Parkinsonian syndromes, including Parkinson's disease, atypical, drug induced, secondary Parkinsonism, heredo-degenerative diseases, as well as other movement disorders with overlapping features.

The journal was acquired by Dove and launched in August 2012. Dove is currently accepting new articles that comply with its publishing guidelines. According to Tim Hill, publisher of Dove Medical Press Ltd., "We are looking forward to assisting this journal with international expansion and recognition, while growing it to the level of many of our impact factor publications."

Qualified physicians, professors and other industry experts are urged to contact Dove with new submissions and reviews to feature their expertise and experience in the journal.

Dove Medical Press is an international provider of high-quality, peer-reviewed medical journals. Our readers, authors, and editors are researchers, academics, clinicians, and other professionals from the international healthcare community.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/8/prweb9805878.htm